Glaxosmithkline | GSK - الدين

سعر السهم
51.41
التغيير اليومي
-7.71 -13.04%
شهريا
-13.25%
سنويا
29.01%
Q2 التوقعات
53.52




الدين تغيير تاريخ
AbbVie USD 67.5B 67.5B 2025-12
Amgen USD 54.59B 1.62B 2025-09
AstraZeneca USD 29.62B 3.01B 2025-12
Aurora Cannabis CAD 100.34M 1.29M 2025-09
Bausch Health Companies USD 20.85B 191M 2025-12
Bristol-Myers Squibb USD 51.04B 112M 2025-09
Canopy Growth CAD 259.33M 68.47M 2025-09
Corcept Therapeutics USD 6.36M 247K 2025-09
Drreddys Laboratories INR 67.73B 19.09B 2025-12
Eli Lilly USD 42.51B 2.6B 2025-09
GlaxoSmithKline GBP 17.72B 30M 2025-12
Glaxosmithkline GBP 17.75B 396M 2025-09
J&J USD 47.93B 2.14B 2025-12
Merck USD 41.37B 5.97B 2025-09
Novartis USD 35.38B 2.74B 2025-12
Pacira USD 372.19M 4.53M 2025-12
Perrigo USD 3.64B 7.2M 2025-09
Pfizer USD 60.85B 78M 2025-09
Phibro Animal Health USD 474.17M 730K 2024-09
Prestige Brands USD 1.04B 1.7M 2025-09
Roche Holding CHF 33.03B 1.41B 2025-06
Sanofi EUR 20.33B 1.43B 2025-12
Supernus Pharmaceuticals USD 42.21M 10.44M 2025-09
Takeda JPY 4.85T 208B 2025-12
Teva Pharmaceutical Industries USD 17.09B 21M 2025-12
Zoetis USD 7.27B 482M 2025-09